Comparative Effectiveness Research in Lung Diseases and Sleep Disorders: Recommendations from the National Heart, Lung, and Blood Institute Workshop
- 1 October 2011
- journal article
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 184 (7) , 848-856
Abstract
The Division of Lung Diseases of the National Heart, Lung, and Blood Institute (NHLBI) held a workshop to develop recommendations on topics, methodologies, and resources for comparative effectiveness research (CER) that will guide clinical decision making about available treatment options for lung diseases and sleep disorders. A multidisciplinary group of experts with experience in efficacy, effectiveness, implementation, and economic research identified (a) what types of studies the domain of CER in lung diseases and sleep disorders should include, (b) the criteria and process for setting priorities, and (c) current resources for and barriers to CER in lung diseases. Key recommendations were to (1) increase efforts to engage stakeholders in developing CER questions and study designs; (2) invest in further development of databases and other infrastructure, including efficient methods for data sharing; (3) make full use of a broad range of study designs; (4) increase the appropriate use of observational designs and the support of methodologic research; (5) ensure that committees that review CER grant applications include persons with appropriate perspective and expertise; and (6) further develop the workforce for CER by supporting training opportunities that focus on the methodologic and practical skills needed.Keywords
This publication has 33 references indexed in Scilit:
- A call for action: Comparative effectiveness research in asthmaJournal of Allergy and Clinical Immunology, 2011
- Training and Career Development for Comparative Effectiveness Research Workforce Development: CTSA Consortium Strategic Goal Committee on Comparative Effectiveness Research Workgroup on Workforce DevelopmentClinical and Translational Science, 2010
- Instrumental variable methods in comparative safety and effectiveness researchPharmacoepidemiology and Drug Safety, 2010
- White Paper on CTSA Consortium Role in Facilitating Comparative Effectiveness ResearchClinical and Translational Science, 2010
- The New Sentinel Network — Improving the Evidence of Medical-Product SafetyNew England Journal of Medicine, 2009
- Prioritizing Comparative-Effectiveness Research — IOM RecommendationsNew England Journal of Medicine, 2009
- Audit and feedback: effects on professional practice and health care outcomes2006
- Indications for Propensity Scores and Review of their Use in PharmacoepidemiologyBasic & Clinical Pharmacology & Toxicology, 2006
- Antenatal betamethasone and incidence of neonatal respiratory distress after elective caesarean section: pragmatic randomised trialBMJ, 2005
- Effects of Limiting Medicaid Drug-Reimbursement Benefits on the Use of Psychotropic Agents and Acute Mental Health Services by Patients with SchizophreniaNew England Journal of Medicine, 1994